Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scholar Rock Holding Corp
(NQ:
SRRK
)
15.35
+0.25 (+1.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Scholar Rock Holding Corp
< Previous
1
2
3
4
Next >
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 15, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at the Jefferies Healthcare Conference
June 01, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress
May 09, 2023
From
Scholar Rock, Inc.
Via
Business Wire
Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference
May 08, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors
April 10, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress
March 07, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 01, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
February 06, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
January 09, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
November 14, 2022
From
Scholar Rock
Via
Business Wire
Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
November 10, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
November 09, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock to Participate in Upcoming Investor Conferences
November 08, 2022
From
Scholar Rock
Via
Business Wire
New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA
October 22, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting
October 06, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
October 04, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer
September 20, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at Upcoming ACCP Annual Meeting and World CB & CDx Summit
September 16, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Second Quarter 2022 Financial Results and Highlights Business Progress
August 08, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors
July 26, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock to Participate in the 2022 Wedbush PacGrow Healthcare Conference
July 19, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present New Preclinical Data on its Targeted Approach to the LTBP-TGFβ1 Complex for Anti-Fibrotic Therapy at the 2022 FASEB Science Research Conference
July 15, 2022
From
Scholar Rock
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.